Ionis Invests For The Future In New Technologies, Manufacturing Innovation

Antisense Pioneer Looks Beyond Brain, Heart And RNA

3D Model of DNA/RNA
Ionis is investing beyond RNA in gene-editing medicines • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from R&D

More from Scrip